Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Medical Startup Investors in United Kingdom

Last updated: Apr 2024 A list of 50 angel investors and VC funds that invest in Medical startups based in United kingdom. We rank investors based on the number of investments they made in Medical companies from United kingdom. We update this investor list every month.

Top 50 Medical Startup Investors in United Kingdom

Investor	Medical United Kingdom investments
Parkwalk Advisors	21
UK Innovation & Science Seed Fund	20
Scottish Enterprise	18
Deepbridge Capital	18
Oxford Science Enterprises	16
Oxford Technology Management	15
Archangels	14
Scottish Investment Bank	13
Mercia Fund Managers	13
Development Bank of Wales	12
GM&C Life Sciences Fund	12
AlbionVC	12
Oxford Science Enterprises	12
Newable Private Investing	11
Oxford Capital	10
Cambridge Innovation Capital	10
Catapult Ventures	10
IP Group	9
Nesta Ventures	9
Jonathan Milner	9
Northstar Ventures	9
Wellcome Trust	8
Providence Investment Company Limited	8
Future Planet Capital	7
SyndicateRoom	7
M Ventures	6
Foresight Group	6
Oxford Investment Consultants LLP	6
Business Growth Fund	6
Tern	6
Nina Capital	6
Praetura Ventures	6
Calculus Capital	6
Woodford Investment Management	5
QUBIS	5
Co-FundNI	5
SIS Ventures	5
Invest Northern Ireland	5
Syncona Partners LLP	5
Angels 5K	5
Angels in MedCity	5
Innovate UK	5
VentureFounders	5
Kelvin Capital	5
TRICAPITAL	5
Midven	4
Amadeus Capital Partners	4
Epidarex Capital	4
Longwall Venture	4
UCLB	4

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Investment focus

Biotechnology, Health Care, Software
Seed, Series A, Series B
United Kingdom, United States, Philippines

Portfolio highlights

Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
Adsilico — Adsilico redefines medical device innovation.
Wayland Additive — Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing. Wayland’s goal is to develop, manufacture and sell metal Additive Manufacturing (“AM” – 3D printing) machines to industrial end-users such as major players in the aerospace and medical industries.

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Investment focus

Biotechnology, Health Care, Medical
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
Oxford Space Systems — Oxford Space Systems is a multi-award-winning, record-breaking venture capital backed, space tech business that's developing a new generation of deployable antennas and space structures for the global satellite industry. Using both innovative design techniques such as origami and novel proprietary materials developed by the company, OSS'structures are lighter, less complex and lower cost than alternatives in commercial demand. Founded in late 2013, OSS set a record for the space sector with it's AstroTube Boom: the fastest development of a new product from concept to successful deployment on orbit in under 30 months. Today, the 18 strong and growing OSS team is a diverse mix of international graduates and experienced space industry professionals, with over 100 years of combined space sector experience. OSS investors include a small syndicate of UK venture capital funds together US based investors, Space Angels. Oxford Space Systems has successfully completed a number of UK government supported co-developments with leading European satellite builders as well straight commercial contracts in both Asia and the US. As part of its planned expansion, OSS move into its own custom facility at the Harwell Space Cluster in August 2018, giving it the largest clean room at the cluster. The facility will meet required security standards to undertake UK government defense & security contracts. .
Laverock Therapeutics — Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.

Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.

Investment focus

Biotechnology, Software, Health Care
Grant, Funding Round, Seed
United Kingdom, United States, Japan

Portfolio highlights

Itza — Itza offers digital learning media and technology business focused on teens.
ilosta — Ilosta specializes in developing novel technology to reduce the cost, time, and dangers associated with monitoring the health of engineering structures and extending their lifespan without requiring human intervention.
QuickBlock — Interlocking blocks is the best way to summarise how QUICKBLOCK works to a novice. Our interlocking blocks click together to build desired structures.

Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.

Investment focus

Health Care, Biotechnology, Medical
Seed, Funding Round, Series A
United Kingdom, Australia, Singapore

Portfolio highlights

Circada — Innovative Circadian lighting reconnects the body clock with nature
Microplate Dx — Safeguarding against the spread of antimicrobial resistance worldwide.
GenoMe Diagnostics — GenoME Diagnostics - We are developing a blood test for an earlier and more accurate diagnosis of ovarian cancer.GenoME Diagnostics .

Oxford Sciences Innovation is the world’s largest university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companiestaking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Investment focus

Health Care, Biotechnology, Software
Seed, Series A, Funding Round
United Kingdom, United States, Finland

Portfolio highlights

Navenio — Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons orwi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice.The company was founded in 2015 and is headquartered in Oxford, England.
Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
Oxford Quantum Circuits — Oxford Quantum Circuits developing technology using the power of quantum to do things which have never been achieved before, from enabling life-changing drug discoveries to developing new battery technologies.

Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.

Investment focus

Biotechnology, Health Care, Software
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

OxCan — Enabling curative cancer treatment through early detection
Machine Discovery — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

Investment focus

Software, Biotechnology, Health Care
Funding Round, Seed, Series A
United Kingdom, United States

Portfolio highlights

Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
1inhaler — 1inhaler operates as a developer of drug delivery device.
Cytomos — Cytomos develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma and cell therapy domains.

Speak with our Entrepreneurship Team, who can help you find sources of finance, engage with funders and secure investment to grow your business.

Investment focus

Software, Biotechnology, Information Technology
Funding Round, Seed, Series A
United Kingdom, United States, France

Portfolio highlights

Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
Administrate — Manage 100% of enterprise training operations with configurable training management software, designed to scale with your organization.

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Investment focus

Software, Health Care, Biotechnology
Seed, Funding Round, Series A
United Kingdom, United States, Hungary

Portfolio highlights

Kuano — Kuano provides innovative quantum and AI solutions for drug discovery and design. It offers a discovery platform that combines target quantum mapping and AI-led chemistry to enable the faster development of better drug candidates.
MGISS — Independently advising on the smarter use of Geospatial data, technology and the digital transformation of field operations.
Workbuzz — Give your Everyday Heroes a voice with employee engagement surveys. Our flexible and simple survey platform reaches all employees, wherever they are. Book a demo now!

Development Bank of Wales is formed in 2001 by the Welsh Assembly Government. Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Investment focus

Software, Health Care, Biotechnology
Seed, Funding Round, Debt Financing
United Kingdom, Australia, United States

Portfolio highlights

Bikmo — Bikmo exists to enable you to ride more.We build awesome insurance products to protect our customers for unexpected events, use technology to make taking out and managing your policy ultra-simple, and provide exceptional customer experiences through our team of bike geeks.We’re now 5 years into our mission to enable anyone, anywhere, to protecttheir lifestyle, so they can spend more time enjoying it. And, become the brand that resonates with and protects the passion and drive behind the bike and adventure sports community.At the heart of our business is a bunch of bike and adventure sports geeks who choose to spend their free time in the epic wild places our earth has to offer and we want to continue to be able to do just that.
Hope Macy — Hope Macy is a dynamic and expanding financial technology company. Its primary focus is on consumers who require additional security in managing their money, as well as those in the subprime sector.
Validient — Digitally automated compliance and due diligence solutions. Empower your business with the ultimate advantage.

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

Investment focus

Health Care, Biotechnology, Medical
Seed, Funding Round, Series A
United Kingdom, Italy, Germany

Portfolio highlights

ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.

AlbionVC supports visionary founders with long-term capital and scale-up expertise. Founded in 1996, today we are partners to UK early-stage B2B software and healthcare companies. AlbionVC manages c. $1 billion of venture funds, currently invested in over 50 companies. AlbionVC is the technology investment arm of Albion Capital Group LLP, which isauthorised and regulated by the Financial Conduct Authority.

Investment focus

Software, Health Care, Information Technology
Series A, Funding Round, Seed
United Kingdom, United States, France

Portfolio highlights

kennek — Connected infrastructure for loans & credits
Accelex — Accelex Technology, the technology solution to automate the acquisition, analysis and reporting of critical investment data. Learn more today.
OpenDialog AI — OpenDialog is the only conversational AI automation software to safely harness the most advanced Generative AI & LLMs in regulated sectors.

Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI & software, and deep tech.

Investment focus

Biotechnology, Health Care, Software
Series A, Seed, Series B
United Kingdom, United States, The Netherlands

Portfolio highlights

Archangel Lightworks — Archangel Lightworks is integrating space and air assets using laser communication.
Grey Wolf Therapeutics — By targeting the ERAP proteases in the antigen presentation pathway Grey Wolf aims to change the neoantigen repertoire in cancer.
Quantum Motion — One Hundred Qubits is Interesting. One Million is World-changing

Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution

Investment focus

Software, Health Care, Biotechnology
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
RAB Microfluidics — We diagnose early signs of failure in lubricated machinery and prevent equipment failure using our patented microfluidic technology and AI technology.

Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.

Investment focus

Software, Mobile, Health Care
Funding Round, Seed, Series A
United Kingdom, United States, France

Portfolio highlights

Scan.com — Use scan.com to find the best medical imaging centers near you Find an MRI scan, CT scan, X-ray Scan, or other diagnostic imaging scan with scan.com.
HelloSelf — The UK's Trusted Online Private Clinical Therapy Service
TextMine — Legislate is an easy-to-use contract management platform which provides a suite of customisable contracts for businesses and landlords.

Cambridge Innovation Capital backs life sciences and technology companies with an affiliation to Cambridge, Europe’s capital for innovation. As a preferred investor for the University of Cambridge, they have unparalleled access to investment opportunities in the ecosystem.Since our inception in 2013, they have raised £275 million to invest indisruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, the internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health, and genomics/proteomics.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Seed
United Kingdom, United States, Ireland

Portfolio highlights

Riverlane — Riverlane's mission is to make quantum computing useful far sooner than previously imaginable, starting an era of human progress as significant as the industrial and digital revolutions.
T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is

The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Funding Round, Seed, Series A
United Kingdom, United States, Israel

Portfolio highlights

Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
Urban Machine — Urban Machine pioneers sustainable wood reclamation. The Machine leverages robotics and AI technology to transform the construction industry by reducing wood waste and promoting circular practices.
Pencil Biosciences — Next Generation Genome Editing Tool

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Investment focus

Health Care, Biotechnology, Therapeutics
Seed, Series A, Series B
United Kingdom, United States, Australia

Portfolio highlights

AccelerComm — Our patented, market-leading IP solutions for 4G and 5G are configurable for quick, high-performance implementations across a wide range of applications.
Deep Render — Deep Render Ltd. is a spin-out from the Department of Computing at Imperial College London. We are a London based AI start-up that is developing the next generation of media compression algorithms. Our proprietary and patented technology is at the forefront of machine learning research. Furthermore, our Biological Image Compression results arestate-of-the-art, providing at least a 50% efficiency gain over the previous standards
Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.

We bring bold ideas to life to change the world for good.

Investment focus

Biotechnology, Medical Device, Medical
Funding Round, Seed, Series A
United Kingdom, United States

Portfolio highlights

Citymart — Citymart powers cities to deliver services that work. Following best practices developed with leading cities around the world, Citymart connects cities and revolutionizes the way cities frame needs, complete procurements, and improve service delivery. Over 100 cities in 35 countries have adopted Citymart tools and methods to-date.
Featurespace — Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countriesto prevent fraud and financial crime.ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.
Radio Physics Solutions — Radio Physics Solutions is a security and investigation company that specializes in the fields of real-time concealed threat detection, Up to 30m Distance, autonomous, and unobtrusive. It specializes in providing early warning of threats concealed under peoples’ clothes, and so reduce the number of casualties caused by terrorists and criminalsglobally at schools, train stations, airports, government and military installations, tourist attractions and entertainment venues.Radio Physics Solutions was founded in 2009 and headquartered in Cambridgeshire, United Kingdom.

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Series B
United Kingdom, United States, Canada

Portfolio highlights

Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
Pencil Biosciences — Next Generation Genome Editing Tool
Relation Therapeutics — Relation uses machine learning to develop drugs for pressing unmet need.

Northstar Ventures is a venture capital firm investing in innovative solutions to help solve the most pressing societal issues we have today. Our ticket sizes range from £100k to £500k into early stage tech companies. We provide added value in leveraging our network of university partners, funders, non-executive directors and talent to supporteach investment.

Investment focus

Software, E-Commerce, SaaS
Seed, Funding Round, Series A
United Kingdom, United States, Estonia

Portfolio highlights

DayaTani — DayaTani supplies farmers with comprehensive services to increase their productivity.
MarraBio — MarraBio Ltd. is a spin out company from Newcastle University using engineered bacterial protein polymers to provide bioactivity to cells at the industrial scale in the cultivated meat sector and beyond.
Circadacare — Circadacare offers a broad approach to circadian lighting products for the care home industry. We are one of the most reliable circadian lighting company in UK.

Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Grant, Series C, Funding Round
United States, United Kingdom, Germany

Portfolio highlights

Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
DataDotOrg — data.org brings together philanthropy, technology, academia, and social impact organizations to build the field of data science for social impact.
Feinstein Institute for Medical Research — Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes ofbehavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.

Providence Investment Company

Investment focus

Biotechnology, Biopharma, Medical
Funding Round, Series B, Seed
United Kingdom

Portfolio highlights

evonetix — Spearheading a radical new approach to gene synthesis to improve access to high-quality, gene-length DNA. Redefine possible.
DefiniGEN — Generate metabolic disease phenotypes in primary-like human cells using the best-in-class human iPSC differentiation platform. Find out more here!
CellCentric — CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga.The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.

Brilliant Ideas. Brilliant People. Brilliant Minds.

Investment focus

Biotechnology, Health Care, Software
Funding Round, Seed, Convertible Note
United Kingdom, United States, Singapore

Portfolio highlights

Captura — Captura mission is globally scalable carbon capture to support a sustainable future for the climate.
Regent — We build all-electric, passenger-carrying, wing-in-ground-effect vehicles to service coastal routes with technology available today.
Pencil Biosciences — Next Generation Genome Editing Tool

SyndicateRoom is fintech company made up of data-scientists, investment professionals, software developers and marketers with one mission: to be an early investor in every British startup success story.To do this – and make fund investors money – we don’t try to spot the next Big Thing.Instead, we apply a data-driven model to portfolioconstruction; a repeatable process designed to maximise returns and minimise risk for fund investors. As such, we build startup portfolios that don’t attempt to predict the future; they work to stack the odds in investors’ favour.Our fund, Access EIS, aims to build investors a diversified portfolio of 50+ companies by co‑investing exclusively with some of the UK’s best-performing angel investors.

Investment focus

Health Care, Software, Medical
Seed, Equity Crowdfunding, Funding Round
United Kingdom, United States, India

Portfolio highlights

Unfabled — Menstrual care and wellness products for your cycle. Organic period products in sustainable packaging. Curated brands for skincare, sleep, cravings, cramping, mood swings, and relaxation. For all your self-care needs, we have you covered.
Evaro — Evaro provides digital health integration to increase accessibility of pharmacy products.
iCustoms — ClearCustoms use AI & ML to reduce 200m new annual customs declarations time

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Switzerland, United Kingdom

Portfolio highlights

Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
DISCO Pharmaceuticals — DISCO Pharmaceuticals is a firm that specializes in large-scale surfaceome unlocking of cancer cells.
Polaris Electro-Optics — Polaris Electro-Optics empowers integrated photonics for communications and computation.

Foresight Group is a listed infrastructure and private equity investment manager which has been managing funds on behalf of institutions and retail clients for more than 35 years. Foresight has over £7.2 billion of assets under management across a number of funds on behalf of some of the world’s largest institutional investors, family offices,private and high net-worth individuals and retail investors. Foresight's investment strategies are underpinned by a strong environmental, social & governance (“ESG”) focus, which increasingly meets the demands of today’s investors and ensures we are consistently working towards creating a sustainable legacy for future generations.

Investment focus

Software, Health Care, Manufacturing
Funding Round, Private Equity, Seed
United Kingdom, United States, Jersey

Portfolio highlights

Inoviv — Inoviv biomarker tests to support novel therapies
Live Group — Live Group delivers global events and communication strategies to create connections, spark moments, inspire action and deliver better ROI. Find out more.
Family Adventures Group — Family Adventures Group operates as a children's nursery and play provider.

xford Investment Consultants LLP ("OIC") advises Thompson Taraz, the Investment Manager of Oxford Technology and Innovations EIS Fund ("OTIF"). OIC is an Appointed Representative of Stoneware Captial LLP, which is authorized and regulated by the Financial Conduct Authority in the United Kingdom.The focus of OIC research ison University of Oxford spin out companies.Over the last fifteen years Oxford has produced a string of world-class spin-out companies. It is our belief that the next generation of world-class Oxford businesses is just waiting to be discovered.

Investment focus

Health Care, Software, Biotechnology
Series A, Seed, Funding Round
United Kingdom

Portfolio highlights

Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
Caristo Diagnostics — Our AI powered CaRi-Heart technology uncovers coronary inflammation, atherosclerosis, and plaque progression on cardiac CT. Learn more about our award-winning technology
Oxford Quantum Circuits — Oxford Quantum Circuits developing technology using the power of quantum to do things which have never been achieved before, from enabling life-changing drug discoveries to developing new battery technologies.

BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.

Investment focus

Software, Information Technology, Health Care
Funding Round, Series A, Private Equity
United Kingdom, Ireland, United States

Portfolio highlights

Trojan Energy — Trojan Energy support the roll-out of its on-street flat and flush electric vehicle charging points, which aims to solve the issue for vehicle owners who do not have access to off-street parking.
Elite Dynamics — Leading software solution developed for Holiday Parks, Marinas, Holiday Home Manufacturers and Holiday Home Dealers.
The Insights Family — The global leader in kids, parents, and family market research. Clarity and confidence from independent real-time data & insights.

Looking for an IoT investor for your start up or early stage company? Tern PLC is a venture capitalist working alongside ambitious entrepreneurs in the Internet of Things (IoT) space to deliver strategic IoT investment to grow your company.

Investment focus

Software, Information Technology, Artificial Intelligence
Funding Round, Seed, Series A
United Kingdom, United States

Portfolio highlights

Konektio — With over 20+ years of industrial IoT experience - Konektio's condition-based and energy-monitoring solutions keep your machines running.
FundamentalVR — A strategic partner helping med-device leaders solve the Competency @ Scale Gap todrive commercial success.
Talking Medicines — Data tech innovator Talking Medicines, based in Glasgow and London, uses advanced AI and ML to provide pharmaceutical companies with real-time data intelligence. The company uses a collection of AI, ML and NLP tech tools to capture and structure the voice of the patient from real world conversations and behaviours at home. Through mapping thepatient voice from social media and connected devices to regulated medicine information, the company is able to build data points to deliver trends and patterns of patient sentiment across medicines. This intelligence embraces regulatory compliance enabling marketing in pharmaceutical companies to measure patient confidence by medicine and in turn action the levers for share growth.

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Investment focus

Health Care, Artificial Intelligence, Software
Seed, Pre-Seed, Series A
United States, United Kingdom, Austria

Portfolio highlights

Ryver — We provide software to generate synthetic medical images and assess their privacy as well as quality
CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of

Praetura Ventures has been supporting entrepreneurs with more than money since 2011. Click to find out more about how we can help businesses and investors.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Series A
United Kingdom

Portfolio highlights

Covatic — We help media companies deliver private-by-design, addressable advertising and marketing without exposing personal data.
Decently — Decently provides the world a better place by developing advanced digital products. Decently mission is to improve lives through innovative digital product.
Percayso Inform — Percayso provides insurers with access to a wide range of data sources, allowing them to form a more comprehensive view of their customers.

At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile.They look to make £2-5 million investments in established companies with provenmanagement teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.

Investment focus

Biotechnology, Software, Health Care
Funding Round, Series A, Post-IPO Equity
United Kingdom, United States, Ireland

Portfolio highlights

Tagomics — Tagomics transform disease diagnosis through comprehensive multitopic profiling.
Arctic Shores — Unearth meaningful, job-relevant insights through our candidate assessments. A new type of behaviour based assessment that's powered by neuroscience.
Laverock Therapeutics — Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.

Woodford Investment Management is a privately owned investment firm manages equity mutual funds. At Woodford, they don’t want to be just another fund management company. They want to create something different and better for their investors and they feel strongly that existing and potential clients are entitled to understand what they are doingwith their money.As investors, they are active, engaged, long-term, disciplined, diligent and focused. That’s a lot of things to say about their selves but each word is important in helping you to understand how they manage money – they will explain in more detail as they move along.Their investment approach and process are focused on value discovery, not price discovery. They believe that financial markets are inherently inefficient and that, through disciplined and diligent analysis, they can identify investment opportunities where market prices do not reflect long-term fundamental value. By exploiting this pervasive market characteristic, they believe they can create real long-term value for their investors.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
United Kingdom, United States, Ireland

Portfolio highlights

Inivata — Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients.Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumor DNA (ctDNA) which can be collectedthrough a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored, and treated.
Revolut — Join 40+ million customers globally using Revolut to send money to 160+ countries, hold up-to 36 currencies in app, spend in 150+ currencies, and manage their money.
Atom Bank — Savings accounts, a range of mortgages & business loans, you'll find it all with Atom bank. App-based and designed to be hassle-free. Download the app today.

QUBIS Ltd was established in 1984 by The Queen's University of Belfast to commercialise the University's research and development activities through the formation of 'spin-out' businesses. Qubis Ltd is an investment vehicle, holding company which takes an equity holding in a new spin-out venture in return for an investment ofcash and/or Intellectual Property. Qubis Ltd 'pulls through' appropriate R & D from the laboratory into the commercial market place.

Investment focus

Health Care, Medical, Biotechnology
Seed, Funding Round, Pre-Seed
United Kingdom, United States

Portfolio highlights

VascVersa — VascVersa is a new cell therapy company based in Northern Ireland. At VascVersa we are developing medicines to create new blood vessels, repair tissue and promote healing.
CV6 Therapeutics — CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies for the treatment of human diseases.
GenoMe Diagnostics — GenoME Diagnostics - We are developing a blood test for an earlier and more accurate diagnosis of ovarian cancer.GenoME Diagnostics .

Through Co-Fund NI £12.5million will be made available to invest alongside business angels and business angel syndicates (hereafter referred to as "private investors" or "syndicates") into eligible SME's based in Northern Ireland. When matched 45% public with 55% private investors on a deal-by-deal basis this will give anoverall "fund" size of £28m.This initiative is provided by Invest Northern Ireland and part-financed by the European Regional Development Fund under the Invest for Growth and Jobs Programme 2014-2020.

Investment focus

Software, Health Care, Information Technology
Seed, Funding Round, Pre-Seed
United Kingdom, Ireland

Portfolio highlights

Kinsetsu — Kinsetsu provides intelligent tracking solutions to help organisations automate and optimise tasks and services.
CV6 Therapeutics — CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies for the treatment of human diseases.
GenoMe Diagnostics — GenoME Diagnostics - We are developing a blood test for an earlier and more accurate diagnosis of ovarian cancer.GenoME Diagnostics .

SIS Ventures has been created with the overall aim of supporting and growing high impact organisations through access to mission-aligned investment. SIS Ventures has a goal of becoming the go to investor and partner for social entrepreneurs. The fund will offer conventional financial returns alongside social and/or environmental returns byinvesting either equity or debt into purpose driven companies.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Funding Round
United Kingdom

Portfolio highlights

Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
MiAlgae — MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market.
Microplate Dx — Safeguarding against the spread of antimicrobial resistance worldwide.

Invest Northern Ireland is Northern Ireland's economic development agency. Their overall goal is to help create wealth for the benefit of the whole community by strengthening the economy and helping it grow.

Investment focus

Health Care, Biotechnology, Medical
Funding Round, Grant, Seed
United Kingdom, United States, Ireland

Portfolio highlights

TruCorp — TruCorp: Your source for lifelike Medical Training Equipment. Explore our intubation manikins & airway trainers. Request a free demo today!
Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
CV6 Therapeutics — CV6 Therapeutics is a drug development company focused on the discovery, development and commercialization of novel therapies for the treatment of human diseases.

Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.

Investment focus

Biotechnology, Therapeutics, Medical
Series A, Series B, Seed
United Kingdom, United States, Switzerland

Portfolio highlights

Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Mosaic Therapeutics — Mosaic Therapeutics is reshaping the interface of computational and experimental medicine to power new medicines for patients.
SwanBio Therapeutics — SwanBio Therapeutics is a gene therapy company that aims to bring life-changing treatments to people with devastating, genetically defined neurological conditions.

Southern Angel Investors Club, combining Surrey investors Club & Angels 5K, are entrepreneurs who understand what new businesses need.

Investment focus

Biotechnology, Software, Medical
Seed, Funding Round, Angel
United Kingdom

Portfolio highlights

Celixir — Celixir is a developer of regenerative medicines created to change the lives of patients in need. The company's medicines consists of iMP cells, platelet lysate and PML cells to treat patients with ischaemic heart disease, injured tendons near the surface of the skin and mild to moderate heart failure respectively, enabling medical researchersto discover breakthrough medicines that aim to change the standard of medical care for patients.
Novastone Media — With its unique asymmetric technology, novastone puts you directly where your clients want to talk to you.
Geektastic — Geektastic guarantees hiring teams only meet high calibre candidates. Our technical code challenges quickly identify the most talented software engineers.

Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.

Investment focus

Health Care, Biotechnology, Medical
Seed, Funding Round, Angel
United Kingdom, United States

Portfolio highlights

Atelerix — The Atelerix technology provides an innovative solution for storing and transporting cells and tissues at room temperature.
Clustermarket — The intuitive lab management system for all academic research facilities and industrial laboratories that need to efficiently manage equipment bookings.
DynamX Medical — DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated point-of-care by nurses.

Innovate UK is part of the UK Research and Innovation .

Investment focus

Health Care, Software, Biotechnology
Grant, Seed, Pre-Seed
United Kingdom, United States, Singapore

Portfolio highlights

North AI — North AI operates as an AI start up company for media sector.
SökerData — SökerData is a biotechnology company that provides research, and data analysis solutions for disease-related datasets.
Aelius Biotech — Aelius biotech specialise in the development of models of the mucosal surfaces of the human body. We currently have the capability to model the gastrointestinal tract and the airways, and are in the process of developing model systems to simulate the mucosal surfaces of the eye and cervico-vaginal tract.

Volution is a UK based Venture Capital firm. We back ambitious Fintech and SaaS businesses, ready to accelerate their growth to Series B and beyond.

Investment focus

Health Care, Software, Medical
Series A, Funding Round, Seed
United Kingdom, United States

Portfolio highlights

Zopa — Zopa is a P2P money lending service that allows lenders and borrowers to deal directly with one another, cutting out the banks who act as middlemen. It works in the following way: the company first categorizes borrower credit grades with an A*, A, B, C, or Y rating; then lenders make offers that vary by money amount and time period for persons witha certain credit grade, and borrowers can then agree the aggregate offered rate.Zopa takes on such responsibilities as distributing money between parties, completing the legal paperwork, performing borrower identity/credit checks, and employing a collections agency that chases missed payments for the lender.Zopa also mitigates risk for lenders by enforcing monthly direct debit repayment, making borrowers sign a legal contract, and allowing lenders to lend small chunks of money to individual borrowers (i.e. someone lending Â£1000 would have their money spread across say, 100 borrowers).The company itself makes money by charging a fixed fee for borrowers and a 1% annual fee for lenders.Zopa has received public acclaim as well, having been awarded CNET Technology Awards' 2006 Internet Innovation of the Year, the 2007 Webby Award for Best Banking/Bill-Paying Website, the 2008 Webby Award for Financial Services, the Banker 2007 Award for Best Internet Project, and Moneywise 2009 Awards for Best Customer Service and Best Personal Loan.One of the three initial members of the UK's Peer-to-Peer Finance Association, together with FundingCircle and RateSetter. Other P2P lending services include
DeadHappy — DeadHappy is an insurtech company that provides digital pay-as-you-go life insurance services. It specializes in offering flexible life insurance policies that are designed to be cheaper, easier, and better than existing traditional providers. Its offerings include pricing insurance based on current circumstances and the option to add furthercoverage on a rolling basis.The company was founded in 2013 and is headquartered in Leicester, England.
Lightpoint Medical — Lightpoint is developing miniaturized imaging and sensing tools for advanced robot-assisted cancer surgery.

We invest venture capital in to globally ambitious companies which have the potential to deliver a significant return to our investors

Investment focus

Health Care, Biotechnology, Manufacturing
Seed, Funding Round, Series A
United Kingdom, United States

Portfolio highlights

novosound — Novosound is an award winning Scottish sensors company utilising thin-film processes to eliminate conventional limitations in ultrasound sensors.
Snappy Shopper — Order your favourite products from your local convenience store, for delivery from as little as 30 minutes with Snappy Shopper. Your every day essentials are only a click away - order your grocery delivery online or through our app.
Sofant Technologies — Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.

The TRICAPITAL Syndicate is a business angel cohort of entrepreneurs, CEOs and business leaders who have founded, funded and built companies

Investment focus

Biotechnology, Software, Health Care
Funding Round, Seed, Series B
United Kingdom, France

Portfolio highlights

ŌGI Bio — Offering an affordable route to automating routine microbial culturing with a unique, modular, retrofittable device
Sellmyartworks — SellmyArtworks is to buy and sell pre-loved artwork in a simple, fast, and affordable way like no other pre-owned art seller.
Heero Technologies — Heero Technologies, the leading independent energy platform for making net zero homes a reality

Midven is a specialist venture capital company providing investment to fast growing small and medium sized enterprises ("SMEs"), run by an energetic, experienced and hands-on team of investment managers.

Investment focus

Software, Manufacturing, Information Technology
Funding Round, Seed, Series A
United Kingdom, United States, Israel

Portfolio highlights

Eyoto — Eyoto produces a range of software services such as image processing, computer vision, eye-tracking, and artificial intelligence.
MetCloud — METCLOUD is a next generation, cyber security & cloud platform provider. Contact our team today for pioneering cyber security solutions!
When in Rome — We bring you craft wines made by small, independent producers and sold in convenient, eco-friendly bag-in-boxes at a great price with free delivery.

Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today

Investment focus

Software, Artificial Intelligence, Machine Learning
Series B, Seed, Series A
United Kingdom, United States, Spain

Portfolio highlights

Nu Quantum — Home NU QUANTUM Nu Quantum is a quantum networking start-up building the entanglement fabric essential to scaling quantum computers.
Secondmind — Helping automotive engineers design better cars, faster.
Photonic — We are building a new world through scalable, fault-tolerant quantum technologies.

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

Investment focus

Biotechnology, Therapeutics, Health Care
Series A, Seed, Series B
United Kingdom, United States, Germany

Portfolio highlights

Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
Curve Therapeutics — Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve isdeploying this platform to build a pipeline of novel cancer drugs.

Longwall Ventures invests in innovative, UK based, early stage companies in the healthcare, science and engineering sectors

Investment focus

Biotechnology, Medical Device, Health Care
Funding Round, Seed, Series A
United Kingdom, Germany, Philippines

Portfolio highlights

Wayland Additive — Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing. Wayland’s goal is to develop, manufacture and sell metal Additive Manufacturing (“AM” – 3D printing) machines to industrial end-users such as major players in the aerospace and medical industries.
Caristo Diagnostics — Our AI powered CaRi-Heart technology uncovers coronary inflammation, atherosclerosis, and plaque progression on cardiac CT. Learn more about our award-winning technology
Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.

UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including UniversityCollege Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.

Investment focus

Biotechnology, Medical, Health Care
Seed, Series A, Pre-Seed
United Kingdom

Portfolio highlights

Hazy — Hazy is a UCL AI spin out backed by Microsoft and Nationwide. Our core product is synthetic data - data generated artificially using machine learning techniques, that retains the statistical properties of the real data and can be safely used for analytics and innovation without compromising customers privacy and confidential information. We do itby capturing patterns in the raw data to generate completely synthetic 'hazy' data that maintains the statistical value of the original. This means businesses can unlock their data for innovation freely with safer and faster data provisioning on demand and no compliance, security or privacy risks and procurement delays.
Carbon Re — Carbon Re is a climate tech company using cutting-edge AI solutions to decarbonize cement and steel. Get in touch with us today!
Astroscreen — Astroscreen protects brands and defends democracy from harmful social media manipulation campaigns

Investors by industry

Media (entertainment)

EdTech

Consumer

Climate